Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma
1. 系统已在2025-07-18 21:22:46对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1001/jamaoncol.2023.1363
文献链接: https://jamanetwork.com/journals/jamaoncology/fullarticle/2805681
其他信息:
出版社: American Medical Association (AMA)
作者: Lili Mao; Bin Lian; Caili Li; Xue Bai; Li Zhou; Chuanliang Cui; Zhihong Chi; Xinan Sheng; Xuan Wang; Bixia Tang; Xieqiao Yan; Siming Li; Yan Kong; Jie Dai; Xiaoting Wei; Juan Li; Rong Duan; Huayan Xu; Xiaowen Wu; Yue Yang; Fengzhuo Cheng; Cheng Zhang; Fangzhou Xia; Zheng Pang; Jun Guo; Lu Si